Effect of telephone-assisted smoking cessation programme on the self-efficacy, recurrence in patients with bladder cancer: A study protocol

The aim of this study protocol is to examine the effect of telephone-assisted smoking cessation programme based on the information motivation behavioural skills model on the self-efficacy, smoking behaviour, tumour recurrence and progression in patients diagnosed with non-muscle-invasive bladder cancer. A single-center, single-blind, parallel-group, randomized control trial. The intervention group will receive telephone-assisted smoking cessation programme, while no intervention will be applied to the control group. Face-to-face smoking cessation training will be provided for the information component of the programme, motivational interview will be conducted via WhatsApp for its motivation component. Motivational interviews will be undertaken in total of six sessions organized at two-week intervals. The patients' chronic disease management self-efficacy, smoking behaviour will be evaluated at the third, sixth, 12th months. Tumour recurrence, progression will be followed up by cystoscopy at the third, 12th months. This is a randomized controlled study protocol, results are not available at the time of the submission. All results will be reported on the completion of this study. This study protocol, will involve the implementation of comprehensive smoking cessation programme that is much needed for the target population around the world. It is expected that the use of this programme will increase the self-efficacy of smokers with bladder cancer, decrease their smoking behaviour and amount of smoking, eliminate tumour recurrence. Smoking is the most important, modifiable risk factor for bladder cancer. In this study, it is expected that the implementation of telephone-assisted smoking cessation programme based on the information–motivation–behavioural skills model will increase self-efficacy in cancer management and decrease smoking behaviour, tumour recurrence in patients diagnosed with bladder cancer. In the literature, there is no smoking cessation programme based on this model intended for patients diagnosed with bladder cancer.